LON:SALV

SalvaRx Group Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
4.50
MA: GBX 4.50
4.50
52-Week Range N/A
Volume50,758 shs
Average Volume50,758 shs
Market Capitalization£1.65 million
P/E Ratio0.03
Dividend YieldN/A
BetaN/A
SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1624-811611
Employees2
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£64.50 million
Book ValueGBX 15.40 per share

Profitability

Miscellaneous

Market Cap£1.65 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

SalvaRx Group plc (LON:SALV): Are Analysts Optimistic?
April 30, 2020 |  finance.yahoo.com
Salvarx Group Plc Share Chat
February 18, 2020 |  www.lse.co.uk
SalvaRx Turns To Interim Profit, Evaluating Takeover Opportunities
September 26, 2019 |  www.morningstar.co.uk
Salvarx Group Plc Share Chat (SALV)
July 21, 2019 |  www.lse.co.uk
Portage Announces Change of CEO
May 6, 2019 |  finance.yahoo.com
Shareholders approve Acquisition of SalvaRx Limited
January 8, 2019 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.81 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive SALV News and Ratings via Email

Sign-up to receive the latest news and ratings for SALV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SalvaRx Group (LON:SALV) Frequently Asked Questions

What stocks does MarketBeat like better than SalvaRx Group?

Wall Street analysts have given SalvaRx Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SalvaRx Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are SalvaRx Group's key executives?

SalvaRx Group's management team includes the following people:
  • Mr. Denham Hervey Newall Eke, CFO & Director (Age 67)

Who are some of SalvaRx Group's key competitors?

What other stocks do shareholders of SalvaRx Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Bacanora Lithium (BCN), AutoZone (AZO), Angus Energy (ANGS), Allergy Therapeutics (AGY) and (AFR.L) (AFR).

What is SalvaRx Group's stock symbol?

SalvaRx Group trades on the London Stock Exchange (LON) under the ticker symbol "SALV."

How do I buy shares of SalvaRx Group?

Shares of SALV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does SalvaRx Group make?

SalvaRx Group has a market capitalization of £0.00 and generates £64.50 million in revenue each year.

How many employees does SalvaRx Group have?

SalvaRx Group employs 2 workers across the globe.

What is SalvaRx Group's official website?

The official website for SalvaRx Group is www.salvarx.io.

Where are SalvaRx Group's headquarters?

SalvaRx Group is headquartered at Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man.

How can I contact SalvaRx Group?

SalvaRx Group's mailing address is Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man. The company can be reached via phone at +44-1624-811611.


This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.